Neurogene Inc. Accumulated Other Comprehensive Income
Neurogene Inc. (NGNE) had Accumulated Other Comprehensive Income of $0 as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-11-14
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$13.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $18.00K.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$21.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$13.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $18.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | -$21.00K 10-Q · filed 2023-11-14 | |
| 2022-09-30 | -$92.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$72.00K 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-20 | |
| 2018-06-30 | -$2.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$24.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$70.00K 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$103.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | -$205.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$205.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$169.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | -$8.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $72.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$47.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$290.00K 10-K · filed 2017-03-09 | |
| 2015-09-30 | $3.00K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $4.00K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $3.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | -$4.00K 10-K · filed 2016-03-14 | -$3.85K 10-K · filed 2015-03-16 |
| 2014-09-30 | $7.30K 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $880.00 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |